G. Heinz

Reduction of postprandial blood glucose by theα-glucosidase inhibitor Miglitol (BAY m 1099) in Type II diabetes

W. Waldhäusl, M. Komjati, A. Korn, 2004, European Journal of Clinical Pharmacology.

Quantitative evidence of peripheral conversion of angiotensin within the human leg: effects of local angiotensin-I administration and angiotensin-converting enzyme inhibition on regional blood flow and angiotensin-II balance across the leg

S. Gasic, C. Kleinbloesem, G. Heinz, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Contribution of Splanchnic and Peripheral Vascular Tissues to the Disposal of Angiotensin‐II and to Regional Conversion Rates of Angiotensin‐I: A Pilot Study in Humans

S. Gasic, C. Kleinbloesem, W. Waldhausl, 1991, Journal of cardiovascular pharmacology.

Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive urgencies.

F. Sterz, A. Laggner, M. Hirschl, 1993, The American journal of emergency medicine.

Lack of effect of tenoxicam on dynamic responses to concurrent oral doses of glucose and glibenclamide.

W. Waldhäusl, A. Korn, D. Hartmann, 1990, British journal of clinical pharmacology.

Effects of ACE inhibition with cilazapril on splanchnic and systemic haemodynamics in man.

A. Korn, S. Gasic, C. Kleinbloesem, 1989, British journal of clinical pharmacology.

Urinary Concentration and Dilution

K. H. Langer, W. Thoenes, G. Fülgraff, 1969 .